Berlin - Delayed Quote EUR

AC Immune SA (IMR.BE)

1.7820
+0.2820
+(18.80%)
At close: June 6 at 9:52:12 PM GMT+2
Currency in CHF All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
28,299
27,309
14,801
3,935
0
Operating Expense
79,979
79,687
68,425
74,782
79,010
Operating Income
-51,680
-52,378
-53,624
-70,847
-79,010
Net Non Operating Interest Income Expense
3,103
3,063
868
-286
5,904
Other Income Expense
-3,503
-1,598
-1,467
393
113
Pretax Income
-52,080
-50,913
-54,223
-70,740
-72,993
Tax Provision
3
3
10
13
3
Net Income Common Stockholders
-52,083
-50,916
-54,233
-70,753
-72,996
Diluted NI Available to Com Stockholders
-52,083
-50,916
-54,233
-70,753
-72,996
Basic EPS
-0.52
-0.51
-0.64
-0.85
-0.97
Diluted EPS
-0.52
-0.51
-0.64
-0.85
-0.97
Basic Average Shares
99,947.7980
99,835.2940
84,694.6160
83,554.4120
74,951.8330
Diluted Average Shares
99,947.7980
99,835.2940
84,694.6160
83,554.4120
74,951.8330
Total Operating Income as Reported
-51,680
-52,378
-53,624
-70,847
-79,010
Total Expenses
79,979
79,687
68,425
74,782
79,010
Net Income from Continuing & Discontinued Operation
-52,083
-50,916
-54,233
-70,753
-72,996
Normalized Income
-49,981.2000
-49,453.8300
-52,890.6950
-71,094.9100
-73,105.6100
Interest Income
3,254
3,196
1,044
69
6,485
Interest Expense
151
133
176
355
581
Net Interest Income
3,103
3,063
868
-286
5,904
EBIT
-51,929
-50,780
-54,047
-70,385
-72,412
EBITDA
-49,711
-48,618
-51,832
-68,026
-70,006
Reconciled Depreciation
2,218
2,162
2,215
2,359
2,406
Net Income from Continuing Operation Net Minority Interest
-52,083
-50,916
-54,233
-70,753
-72,996
Total Unusual Items Excluding Goodwill
-3,503
-1,598
-1,467
393
113
Total Unusual Items
-3,503
-1,598
-1,467
393
113
Normalized EBITDA
-46,208
-47,020
-50,365
-68,419
-70,119
Tax Rate for Calcs
0.0004
0.0001
0.0001
0.0001
0
Tax Effect of Unusual Items
-1,401.2000
-135.8300
-124.6950
51.0900
3.3900
12/31/2021 - 10/6/2016

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

ABRT.CN Albert Labs International Corp.
0.0050
0.00%
 
NXOA.BE Nicox SA
0.2260
-0.88%
 
5CV.HA CureVac NV
3.8120
-0.78%
 
P0F.F Egetis Therapeutics AB (publ)
0.3285
-5.06%
 
2LB.MU Iovance Biotherapeutics Inc
1.5644
0.00%
 
BT1.BE Bone Therapeutics SA
0.0018
0.00%
 
AYJ.HA Valneva SE
2.7240
-1.23%
 
2LB.F Iovance Biotherapeutics, Inc.
1.5496
-4.11%
 
ALINT.PA IntegraGen SA
0.5220
0.00%
 
63E.F Onward Medical N.V.
4.1950
+0.96%